Metropolitan Life Insurance Company (MetLife)’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,860	Closed	-$4.78K	–	2243
2024 Q1	$4.78K	Buy	1,860 +836	+82%	+$2.04K	﹤0.01%	2248
2023 Q4	$2.09K	Sell	1,024 -3,815	-79%	-$6.96K	﹤0.01%	2318
2023 Q3	$8.32K	Hold	4,839	–	–	﹤0.01%	2291
2023 Q2	$9.44K	Buy	+4,839	New	+$11.3K	﹤0.01%	2330
2022 Q1	–	Sell	-10,414	Closed	-$134K	–	2741
2021 Q4	$134K	Hold	10,414	–	–	﹤0.01%	2290
2021 Q3	$112K	Sell	10,414 -235	-2%	-$2.14K	﹤0.01%	2466
2021 Q2	$97.2K	Buy	10,649 +2,972	+39%	+$27.5K	﹤0.01%	2601
2021 Q1	$72.4K	Buy	+7,677	New	+$106K	﹤0.01%	2493
2020 Q3	–	Sell	-10,306	Closed	-$68.4K	–	2597
2020 Q2	$68.4K	Buy	10,306 +1,073	+12%	+$7.23K	﹤0.01%	2451
2020 Q1	$53.7K	Buy	+9,233	New	+$77.5K	﹤0.01%	2362
2019 Q4	–	Sell	-9,730	Closed	-$84K	–	2570
2019 Q3	$84K	Buy	9,730 +7,608	+359%	+$76.9K	﹤0.01%	2394
2019 Q2	$23.6K	Buy	+2,122	New	+$24.3K	﹤0.01%	2585

Other funds holding GRTS

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s GRTS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 1,860 shares — an estimated $4.78K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in GRTS in Q2 2019 and held it in 12 quarters. The position peaked at $134K in Q4 2021. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,860 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $4.78K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Gritstone bio, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
Metropolitan Life Insurance Company (MetLife)'s Gritstone bio, Inc. Common Stock position peaked at $134K in Q4 2021.
79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.